Eyeworld

SEP 2014

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/376249

Contents of this Issue

Navigation

Page 32 of 110

EW CATARACT 30 September 2014 other ophthalmic pathology were excluded. Follow-up examinations were performed 2 weeks and 3 months after surgery, including un- corrected and corrected visual acuity (VA) for far, near, and intermediate distances, subjective refraction, contrast sensitivity under different lighting conditions and amplitude of accommodation. The quality of vision, glare, halos, spectacle inde- pendence, and personal satisfaction of the patients were assessed with a questionnaire. Results: Forty-three cataract patients (86 eyes) from 12 centers have been enrolled in this non-in- terventional, multicenter, prospec- tive observational registry. Mean age 63.5 years, median 65 years. Three months after implantation, mean uncorrected distance VA is 0.99, and 100% of patients are better than 0.8. Mean uncorrected near VA J3.3 and intermediate VA J1.2. Patients' con- trast sensitivity results were above population norm for age 50–75 years. 91% patients did not need glasses for daily activities, driving and reading, and 88% expressed sub- jective satisfaction. Only one patient reported serious/disturbing glare and halo optical phenomena (2.3%). Conclusion: The WIOL-CF IOL provides very good and predictable functional results after surgery and should be considered as a promis- ing IOL for refractive and cataract surgery correcting presbyopia. Dr. Malyugin: This is an interesting lens made of very elastic hydrophilic acrylic material in the Czech Republic with a one-piece design and no haptic elements; it tightly fi lls the entire capsular bag. The mechanism of accommodation mimics the natural lens. The exciting thing is that the im- plant provided very good distance and intermediate vision, and reasonably good near vision. I will be very inter- ested in longer observation specifi cally focusing on the PCO rate because the lens is lacking the sharp edge on its posterior surface. Visual outcomes and patient satisfaction after implantation of multifocal sulcus IOL Victor A. Antunes, MD Purpose: To assess visual outcomes and patient satisfaction following implantation of a multifocal sulcus intraocular lens (IOL) in a single sur- gical procedure combining primary capsular bag lens implantation. Methods: The study included cata- ract patients older than 45 years of age, with hyperopia ≥1.50 D and po- tential acuity measurement ≥20/30, undergoing Sulcofl ex supplementary multifocal IOL (Rayner) implanta- tion in a single session combined with primary capsular bag IOL implantation. Eighty-six percent of eyes received an aspherical distance primary IOL, whereas the remaining received toric distance IOLs. All eyes received a plano multifocal Sulcofl ex lens with +3.5 D addition. Near and distance monocular and binocular visual acuity, refraction, and intra- ocular pressure (IOP) were measured 1 week, and 1, 3, 6, and 9 months after surgery. Patient satisfaction was assessed 1 month postop. Results: The study included 119 eyes (61 patients). 69% of eyes had pre-existing retinal pathologies. At 1 month, 81% of eyes had monoc- ular UDVA 20/25 or better and 91% had monocular UNVA J2 or better. 96% and 93% of eyes, respectively, had binocular UDVA 20/25 or better and binocular UNVA J2 or better. At 3 months, 88% and 51% of eyes, respectively, had spherical and cylindrical refraction within ±0.5 D. Boris Malyugin, MD, PhD, highlighted the best international cataract papers at the "Hot Off the Press" session at the 2014 ASCRS•ASOA Symposium & Congress. The papers were chosen from the 2014 ASCRS Best Paper of Session winners. Here are the abstracts from the studies, with his comments regarding selection. Multicenter observational registry: clinical experience with polyfocal bioanalogic IOL Pavel Stodulka, MD, PhD Purpose: Clinical evaluation of functional results and quality of vision after bilateral implantation of a WIOL-CF bioanalogic, polyfocal, intraocular lens. Methods: The WIOL-CF bioana- logic, polyfocal, accommodative IOL was implanted bilaterally after phacoemulsifi cation with max. 2 weeks between the fi rst and second eye implantation. Patients with any Hot off the press: Dr. Malyugin highlights the best international cataract papers at the "Hot Off the Press" session. Source: EyeWorld Fourth in a series of 5 presentations

Articles in this issue

Archives of this issue

view archives of Eyeworld - SEP 2014